These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 30703440
1. Molecular epidemiology of Clostridioides (previously Clostridium) difficile isolates from a university hospital in Minas Gerais, Brazil. Diniz AN, de Oliveira Júnior CA, Vilela EG, Figueiredo HCP, Rupnik M, Wilcox MH, Fawley WN, Blanc DS, Faria Lobato FC, Silva ROS. Anaerobe; 2019 Apr; 56():34-39. PubMed ID: 30703440 [Abstract] [Full Text] [Related]
2. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1. Tratulyte S, Miciuleviciene J, Kuisiene N. Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067 [Abstract] [Full Text] [Related]
3. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea. Byun JH, Kim H, Kim JL, Kim D, Jeong SH, Shin JH, Kim YA, Shin JH, Shin KS, Uh Y. Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214 [Abstract] [Full Text] [Related]
6. Molecular characterisation of Czech Clostridium difficile isolates collected in 2013-2015. Krutova M, Nyc O, Matejkova J, Allerberger F, Wilcox MH, Kuijper EJ. Int J Med Microbiol; 2016 Nov; 306(7):479-485. PubMed ID: 27519407 [Abstract] [Full Text] [Related]
7. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain. Weber I, Riera E, Déniz C, Pérez JL, Oliver A, Mena A. Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477 [Abstract] [Full Text] [Related]
8. Molecular epidemiology of Clostridium difficile in a tertiary hospital of China. Chen YB, Gu SL, Wei ZQ, Shen P, Kong HS, Yang Q, Li LJ. J Med Microbiol; 2014 Apr; 63(Pt 4):562-569. PubMed ID: 24344206 [Abstract] [Full Text] [Related]
9. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France. Cassir N, Fahsi N, Durand G, Lagier JC, Raoult D, Fournier PE. Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1971-1974. PubMed ID: 28573471 [Abstract] [Full Text] [Related]
13. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. Berger FK, Rasheed SS, Araj GF, Mahfouz R, Rimmani HH, Karaoui WR, Sharara AI, Dbaibo G, Becker SL, von Müller L, Bischoff M, Matar GM, Gärtner B. Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838 [Abstract] [Full Text] [Related]
14. Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases. Hung YP, Lin HJ, Tsai BY, Liu HC, Liu HC, Lee JC, Wu YH, Wilcox MH, Fawley WN, Hsueh PR, Tsai PJ, Ko WC. Anaerobe; 2014 Dec; 30():188-92. PubMed ID: 24956433 [Abstract] [Full Text] [Related]
15. Characterization of the virulence of three novel clade 2 Clostridioides (Clostridium) difficile strains and a two-year screening in animals and humans in Brazil. Diniz AN, Moura LNF, Cruz DSG, Oliveira Junior CA, Figueiredo HCP, Cunha JLR, Vilela EG, Kuijper EJ, Wilcox MH, Lobato FCF, Silva ROS. PLoS One; 2022 Dec; 17(8):e0273013. PubMed ID: 36026500 [Abstract] [Full Text] [Related]
16. Clostridium difficile infection in cancer patients with hospital acquired diarrhea at the teaching hospitals in Iran: Multilocus sequence typing analysis (MLST) and Antimicrobial resistance pattern. Shoaei P, Shojaei H, Khorvash F, M Hosseini S, Ataei B, Esfandiari Z, Vakili B, Rozati M, Safavi AA. Ann Ig; 2019 Dec; 31(4):365-373. PubMed ID: 31268121 [Abstract] [Full Text] [Related]
17. Molecular typing and epidemiology of Clostridium difficile in respiratory care wards of central Taiwan. Wei HL, Wei SH, Huang CW, Shih CH, Huang YW, Lu MC, Hsu JC, Liou YS, Chiou CS. J Microbiol Immunol Infect; 2015 Feb; 48(1):65-71. PubMed ID: 23726464 [Abstract] [Full Text] [Related]
18. Comparison of a newly developed binary typing with ribotyping and multilocus sequence typing methods for Clostridium difficile. Li Z, Liu X, Zhao J, Xu K, Tian T, Yang J, Qiang C, Shi D, Wei H, Sun S, Cui Q, Li R, Niu Y, Huang B. J Microbiol Methods; 2018 Apr; 147():50-55. PubMed ID: 29486225 [Abstract] [Full Text] [Related]
19. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks. López-Ureña D, Quesada-Gómez C, Montoya-Ramírez M, del Mar Gamboa-Coronado M, Somogyi T, Rodríguez C, Rodríguez-Cavallini E. Emerg Microbes Infect; 2016 May 11; 5(5):e42. PubMed ID: 27165560 [Abstract] [Full Text] [Related]
20. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021. Abdrabou AMM, Bischoff M, Mellmann A, von Müller L, Margardt L, Gärtner BC, Berger FK, German C. difficile surveillance group. Anaerobe; 2022 Oct 11; 77():102548. PubMed ID: 35307546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]